Clinical Trial

A Study to Evaluate Efficacy and Safety of HB0043 in Aadult Patients With Moderate to Severe Acne Vulgaris.

Name: A Study to Evaluate Efficacy and Safety of HB0043 in Aadult Patients With Moderate to Severe Acne Vulgaris. — clinical trial record (NCT07449156)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to assess efficacy safety and tolerability of HB0043 in adult patients with moderate to severe AV.

Trial Details

NCT Number	NCT07449156
Lead Sponsor	Shanghai Huaota Biopharmaceutical Co., Ltd. Collaborators: Dermatology Hospital affiliated to Shandong First Medical University
Conditions	Acne Vulgaris
Enrollment	21 participants
Start Date	2026-03-27
Primary Completion	2026-10-27 (estimated)
Study Completion	2027-03-27 (estimated)
Updated on ClinicalTrials.gov	2026-03-04